MedTrace Logo

(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)

NCT01031095 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2014-01-30

Study results available
· View outcomes & findings →

Summary

The hypothesis:

Low dose intracoronary unfractionated heparin is as effective and safe as standard dose intravenous unfractionated heparin on patients with elective percutaneous coronary intervention.

Conditions

Interventions

OTHER

coronary intervention

elective coronary intervention

Sponsors & Collaborators

  • Bursa Postgraduate Hospital

    lead OTHER

Principal Investigators

  • Hasan Arı, MD · Bursa Postgraduate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01031095 on ClinicalTrials.gov